Stocks in news: ConocoPhillips (NYSE:COP), General Motors Company (NYSE:GM), Leggett & Platt, Incorporated (NYSE:LEG), Enbridge Inc. (NYSE:ENB), Johnson & Johnson (NYSE:JNJ)


A ConocoPhillips (NYSE:COP)-led joint venture is seeking to revise production sharing contracts for three new deepwater blocks offshore Bangladesh to allow a 2%/year gas price rise to kick in before first production begins, a company official said Thursday. On Friday shares of ConocoPhillips (NYSE:COP) closed at $64.92. Company’s sales growth for last 5 years was -25.30% and EPS growth for next 5 years is recorded as 8.70%.

General Motors Company (NYSE:GM) is unveiling a new version of its plug-in hybrid Chevrolet Volt as gas hovers near $2 a gallon and the number of buyers who want a fuel-sipping vehicle shrinks. General Motors Company (NYSE:GM) in last trading activity moved down -1.69% to close at $35.59. Company weekly performance is 2.15% while its quarterly performance stands at 15.70%. General Motors Company (NYSE:GM) is -10.00% away from its 52 week high.

Leggett & Platt Incorporated (NYSE:LEG) Commercial Vehicle Products, a Ford Motor Co. upfitter, on 9 January has signed a lease for a 72,000-square-foot build-to-suit facility in Hunt Midwest’s SubTropolis underground business complex. The deal also includes a 13.5-acre underground parking lot for 1,200 Transit vehicles. On last trading day Leggett & Platt, Incorporated (NYSE:LEG) remains unchanged to close at $43.92. Its volatility for the week is 1.74% while volatility for the month is 1.90%. LEG’s sales growth for past 5 years was -1.70% and its EPS growth for past 5 years was 12.10%. Leggett & Platt, Incorporated (NYSE:LEG) monthly performance is 5.55%.

Enbridge (NYSE:ENB) has earned an “A-” credit rating from analysts at Morningstar. The research firm’s “A-” rating indicates that the company is a low default risk. They also gave their stock a three star rating. Enbridge Inc. (NYSE:ENB) has 3.88% insider ownership while its institutional ownership stands at 70.50%. In last trading activity company’s stock closed at $46.75.

Johnson & Johnson (NYSE:JNJ) on 6 January has begun testing an Ebola vaccine in humans intended to counter a strain of the virus similar to the one that has wreaked havoc in West Africa.On last trading day Johnson & Johnson (NYSE:JNJ) decreased -1.36% to close at $104.94. Its volatility for the week is 1.46% while volatility for the month is 1.58%. JNJ’s sales growth for past 5 years was 2.30% and its EPS growth for past 5 years was 1.00%. Johnson & Johnson (NYSE:JNJ) monthly performance is -2.88%.


Leave a Reply

Your email address will not be published. Required fields are marked *